UM  > 健康科學學院
Engineered single human CD4 domains as potent HIV-1 inhibitors and components of vaccine immunogens
Weizao Chen1; Yang Feng1; Rui Gong1; Zhongyu Zhu1; Yanping Wang1,2; Qi Zhao1; Dimiter S. Dimitrov1
2011
Source PublicationJOURNAL OF VIROLOGY
ISSN0022-538X
Volume85Issue:18Pages:9395–9405
Abstract

Soluble forms of the HIV-1 receptor CD4 (sCD4) have been extensively characterized for more than 2 decades as promising inhibitors and components of vaccine immunogens. However, they were mostly based on the first two CD4 domains (D1D2), and numerous attempts to develop functional, high-affinity, stable soluble one-domain sCD4 (D1) have not been successful because of the strong interactions between the two domains. We have hypothesized that combining the power of structure-based design with sequential panning of large D1 mutant libraries against different HIV-1 envelope glycoproteins (Envs) and screening for soluble mutants could not only help solve the fundamental stability problem of isolated D1, but may also allow improvement of D1 affinity while preserving its cross-reactivity. By using this strategy, we identified two stable monomeric D1 mutants, mD1.1 and mD1.2, which were significantly more soluble and bound Env gp120s more strongly (50-fold) than D1D2, neutralized a panel of HIV-1 primary isolates from different clades more potently than D1D2, induced conformational changes in gp120, and sensitized HIV-1 for neutralization by CD4-induced antibodies. mD1.1 and mD1.2 exhibited much lower binding to human blood cell lines than D1D2; moreover, they preserved a β-strand secondary structure and stability against thermally induced unfolding, trypsin digestion, and degradation by human serum. Because of their superior properties, mD1.1 and mD1.2 could be potentially useful as candidate therapeutics, components of vaccine immunogens, and research reagents for exploration of HIV-1 entry and immune responses. Our approach could be applied to other cases where soluble isolated protein domains are needed.

DOIhttps://doi.org/10.1128/JVI.05119-11
Indexed BySCI
Language英语
WOS Research AreaVirology
WOS SubjectVirology
WOS IDWOS:000293956400014
Fulltext Access
Citation statistics
Cited Times [WOS]:24   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionFaculty of Health Sciences
Corresponding AuthorDimiter S. Dimitrov
Affiliation1.Protein Interactions Group, Center for Cancer Research Nanobiology Program, National Cancer Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702
2.Basic Research Program, Science Applications International Corporation-Frederick, Inc., National Cancer Institute-Frederick, Frederick, Maryland 21702
Recommended Citation
GB/T 7714
Weizao Chen,Yang Feng,Rui Gong,et al. Engineered single human CD4 domains as potent HIV-1 inhibitors and components of vaccine immunogens[J]. JOURNAL OF VIROLOGY,2011,85(18):9395–9405.
APA Weizao Chen.,Yang Feng.,Rui Gong.,Zhongyu Zhu.,Yanping Wang.,...&Dimiter S. Dimitrov.(2011).Engineered single human CD4 domains as potent HIV-1 inhibitors and components of vaccine immunogens.JOURNAL OF VIROLOGY,85(18),9395–9405.
MLA Weizao Chen,et al."Engineered single human CD4 domains as potent HIV-1 inhibitors and components of vaccine immunogens".JOURNAL OF VIROLOGY 85.18(2011):9395–9405.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Weizao Chen]'s Articles
[Yang Feng]'s Articles
[Rui Gong]'s Articles
Baidu academic
Similar articles in Baidu academic
[Weizao Chen]'s Articles
[Yang Feng]'s Articles
[Rui Gong]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Weizao Chen]'s Articles
[Yang Feng]'s Articles
[Rui Gong]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.